1071226-27-1

Basic information

• Product Name: methyl (2-p-methylphenyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-α/β-D-galacto-2-thio-nonulopyranosid)onate
• Synonyms: methyl (2-p-methylphenyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-α/β-D-galacto-2-thio-nonulopyranosid)onate
• CAS NO: 1071226-27-1
• Molecular Weight: 597.64
• Mol File: 1071226-27-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: methyl (2-p-methylphenyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-α/β-D-galacto-2-thio-nonulopyranosid)onate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl (2-p-methylphenyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-α/β-D-galacto-2-thio-nonulopyranosid)onate(1071226-27-1)
• EPA Substance Registry System: methyl (2-p-methylphenyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-α/β-D-galacto-2-thio-nonulopyranosid)onate(1071226-27-1)

Safety Data

• Hazardous Substances Data: 1071226-27-1(Hazardous Substances Data)

Upstream product

• 20298-35-5 N-acetylneuraminic acid methyl ester 
• 6931-68-6 methyl 5-acetamido-2,4,7,8,9-penta-O-acetyl-3,5-dideoxy-D-glycero-D-galacto-2-nonulopyranosonate 
• 106-45-6 para-thiocresol 
• 6813-81-6 N-acetyl neuraminic acid 

Downstream Products

• 1071226-28-2 methyl (p-tolyl 4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-thio-5-trichloroacetamido-D-glycero-D-galacto-2-nonulopyranosyl)onate 
• 381716-09-2 methyl (tolyl 5-azido-4,7,8,9-tetra-O-acetyl-3,5-di-deoxy-2-thio-D-glycero-β-D-galacto-non-2-ulopyranoside)onate 
• 374573-39-4 methyl (tolyl 5-azido-4,7,8,9-tetra-O-acetyl-3,5-di-deoxy-2-thio-D-glycero-α-D-galacto-non-2-ulopyranoside)onate 

Relevant articles and documents

Rhamnose modified bovine serum albumin as a carrier protein promotes the immune response against sTn antigen

Rhamnose and sTn antigen were co-conjugated to bovine serum albumin (BSA), a weakly immunogenic carrier protein, for cancer vaccine development. The immune responses against sTn have been significantly augmented with the involvement of Rha-specific antibodies to enhance antigen uptake. This journal is

NEW POTENT SIALYLTRANSFERASE INHIBITORS

The present invention relates to anew class of sialyltransferase inhibitors. The class features a carbamate or similar moiety on the amine of a neuraminic acid derivative. Such inhibitors are suitable for use as a medicament, for example for treating, preventing, or delaying bacterial infection, viral infection, cancer, a disorder of sialic acid metabolism, or an autoimmune disease.